For the quarter ending 2025-09-30, XBIO has $5,067,960 in assets. $1,111,775 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 4,121,599 | 4,779,846 | ||
| Prepaid expenses and other | 946,361 | 573,854 | ||
| Total current assets | 5,067,960 | 5,353,700 | ||
| Other assets | 0 | 0 | ||
| Total assets | 5,067,960 | 5,353,700 | ||
| Accounts payable | 578,250 | 346,828 | ||
| Accrued expenses and other current liabilities | 533,525 | 556,602 | ||
| Total current liabilities | 1,111,775 | 903,430 | ||
| Total liabilities | 1,111,775 | 903,430 | ||
| Preferred stock, value-Series BPreferred Stock | 1,804 | 1,804 | ||
| Common stock, 0.001 par value 10,000,000 shares authorized as of september 30, 2025 and december 31, 2024 1,544,840 shares issued as of september 30, 2025 and december 31, 2024 1,542,139 shares outstanding as of september 30, 2025 and december 31, 2024 | 1,545 | 1,545 | ||
| Additional paid in capital | 208,276,537 | 208,260,682 | ||
| Accumulated deficit | -199,296,255 | -198,786,315 | ||
| Accumulated other comprehensive income | 253,734 | 253,734 | ||
| Treasury stock | 5,281,180 | 5,281,180 | ||
| Total stockholders' equity | 3,956,185 | 4,450,270 | ||
| Total liabilities and stockholders' equity | 5,067,960 | 5,353,700 | ||
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)